AL
HAE icon

Airain Ltd’s Haemonetics HAE Stock Holding History

Airain Ltd’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$321K Buy
+8,132
New +$334K 0.01% 642
2016
Q3 		– Sell
-34,856
Closed -$1.01M – 686
2016
Q2 		$1.01M Buy
+34,856
New +$1.05M 0.06% 317

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Airain Ltd's HAE Position: Q2 2017 in Review

Airain Ltd opened a new position in Haemonetics (HAE) in Q2 2017: 8,132 shares worth $321K. The stake represents 0.01% of the portfolio and ranks #642 among its holdings. This is a return to the name: Airain Ltd previously reported a position in HAE as recently as Q2 2016.

Airain Ltd first reported a position in HAE in Q2 2016 and has held it in 2 quarters since. The position peaked at $1.01M in Q2 2016. 197 funds tracked by Wall St. Rank hold HAE as of Q2 2017.

  • Airain Ltd held 8,132 shares of Haemonetics worth $321K as of Q2 2017.
  • Haemonetics was a new Airain Ltd position in Q2 2017.
  • Haemonetics made up 0.01% of Airain Ltd's portfolio in Q2 2017, its #642 holding.
  • Airain Ltd first reported a position in Haemonetics in Q2 2016 and has held it in 2 quarters since.
  • Airain Ltd's Haemonetics position peaked at $1.01M in Q2 2016.
  • 197 funds tracked by Wall St. Rank held Haemonetics as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.